President of AstraZeneca Canada Inc.
Elaine Campbell is President of AstraZeneca Canada Inc., one of Canada’s leading biopharmaceutical companies. She returned to Canada in 2012 after 16 years of living and working in the United States.
Elaine has more than 23 years experience in the biopharmaceutical industry, including twelve years with AstraZeneca PLC. Her last U.S.-based role was Commercial Brand Leader for the United States BRILINTA® team, where she launched the cardiovascular product in the U.S. market. Prior to this, she held a number of senior leadership roles within the Global Marketing organization including Vice President of Global Primary Care Brands and Vice President of Global Marketed Brands. Elaine has also led the launch of IRESSA® in the U.S. market, as well as the CRESTOR® Global Project Team, including both Commercial and Development groups for that brand.
Prior to joining AstraZeneca, Elaine was a Senior Vice President and member of the Business Operating Team with DuPont Pharmaceuticals, located in the U.S. During her tenure with DuPont Pharmaceuticals, she held various senior leadership roles within the sales and marketing functions in the U.S and Canada.
Elaine is currently Chair of the Rx&D (Canada’s Research-based Pharmaceutical Companies) Ontario Regional Committee. She is also actively involved as a member of the Board for the Advanced Coronary Treatment (ACT) Foundation and MaRS (Medical and Related Sciences) Discovery District, as well as newly serving on the Advisory Board of the University of Toronto Department of Chemical Engineering.
Elaine holds a Bachelor of Applied Science in Chemical Engineering from the University of Toronto and a Master of Business Administration from St. Joseph’s University in Philadelphia. She and her husband have three children, all of whom reside in Ontario.
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. AstraZeneca’s Canadian headquarters are located in Mississauga, Ontario. For more information, please visit the company’s website at www.astrazeneca.ca